Micronized progesterone is a form of the hormone progesterone that has been ground into extremely small particles to help your body absorb it more effectively. It’s chemically identical to the progesterone your ovaries naturally produce, which distinguishes it from synthetic progestins like medroxyprogesterone acetate. Doctors prescribe it most often during menopause hormone therapy to protect the uterine lining, and during pregnancy to help prevent preterm birth in certain high-risk situations.
How Micronization Changes Absorption
Progesterone on its own is poorly absorbed when swallowed. The hormone doesn’t dissolve well in water, which makes it difficult for your gut to pull it into your bloodstream. Micronization solves this by grinding progesterone crystals into particles small enough to dramatically increase surface area, allowing more of the hormone to dissolve and cross into circulation.
In a study comparing different preparations of 200 mg oral progesterone, micronized progesterone suspended in oil produced the highest peak blood levels, reaching about 38 ng/mL within roughly two hours. Other forms, like plain milled progesterone, peaked lower (around 9.6 ng/mL) and took about four hours to get there. The combination of tiny particle size and an oil carrier makes a meaningful difference in how much progesterone actually reaches your system.
How It Differs From Synthetic Progestins
The word “progestin” refers to any compound that acts like progesterone, including lab-created versions with slightly different chemical structures. Micronized progesterone is not a synthetic progestin. It’s bioidentical, meaning its molecular structure matches what your body makes. This distinction matters because the two behave differently in your body, particularly when it comes to long-term safety.
A meta-analysis covering nearly 87,000 postmenopausal women found that those taking estrogen combined with bioidentical progesterone had a 33% lower relative risk of breast cancer compared to those taking estrogen with synthetic progestins. One population-based study within that analysis found no significant increase in breast cancer risk at all among women using estrogen with progesterone, while synthetic progestin users showed a trend toward higher risk. No head-to-head studies have yet compared the two on cardiovascular outcomes like blood clots or heart disease, so that remains an open question.
Uses in Menopause Hormone Therapy
When a woman with an intact uterus takes estrogen for menopause symptoms, she also needs a progestogen to prevent the uterine lining from thickening unchecked, which can lead to endometrial cancer. Micronized progesterone fills that role. The standard approach requires a total of about 2,000 mg per menstrual cycle to fully transform the endometrium into a safe, stable state.
In practice, this is prescribed one of two ways. In a cyclic regimen, you take 200 mg per day for 12 to 14 days of each month, which typically triggers a withdrawal bleed similar to a period. In a continuous regimen, you take 100 mg every day without a break, which most women prefer because it avoids monthly bleeding. Both approaches provide adequate endometrial protection when combined with estrogen.
Uses in Pregnancy
Micronized progesterone is also used to reduce the risk of preterm birth in women identified as high risk. The key screening tool is an ultrasound measurement of cervical length taken between 20 and 24 weeks of pregnancy. Women with a cervix measuring 15 mm or less face a substantially elevated risk of delivering very early.
In a landmark trial published in the New England Journal of Medicine, women with a short cervix who received vaginal progesterone had a spontaneous delivery rate before 34 weeks of 19.2%, compared to 34.4% in the placebo group. That’s a 44% reduction in the risk of early preterm delivery, a significant benefit for a condition where every extra week in the womb improves a baby’s outcomes.
Oral Versus Vaginal Administration
The two main routes for taking micronized progesterone are by mouth and vaginally, and they produce quite different patterns in the body. Oral progesterone hits higher peak blood levels faster, typically within two to three hours. But much of what you swallow passes through the liver first, where a large portion gets broken down before it can circulate. This “first pass” effect means higher systemic peaks but also faster clearance.
Vaginal administration bypasses the liver, delivering progesterone more directly to the uterus with lower but more sustained blood levels. Peak concentrations after vaginal use are considerably lower than oral, but the hormone lingers longer and achieves higher concentrations in uterine tissue. This makes vaginal progesterone the preferred route for pregnancy-related uses, where local uterine effects matter most. Oral progesterone is more commonly prescribed for menopause therapy, where systemic absorption and convenience are priorities.
The Sedative Effect and Sleep
One of the more notable side effects of oral micronized progesterone is drowsiness, and it’s not just a mild nuisance. When your liver processes progesterone, it converts a portion into a metabolite called allopregnanolone. This compound interacts with the same brain receptors that respond to benzodiazepines (drugs like Valium), enhancing the calming neurotransmitter GABA. Research has confirmed that allopregnanolone produces a sleep pattern strikingly similar to what benzodiazepines produce.
This is why doctors recommend taking oral micronized progesterone at bedtime. For many women, especially those struggling with the sleep disruptions of menopause, this sedative property is actually a welcome bonus rather than a drawback. Vaginal progesterone does not produce the same level of drowsiness because it largely avoids liver metabolism and generates far less allopregnanolone.
Common Side Effects
Beyond drowsiness, the most frequently reported side effects of micronized progesterone include breast tenderness, joint or muscle pain, mood changes (including low mood or increased worry), and a white or brownish vaginal discharge. These effects are generally mild and often improve after the first few cycles of use.
Compared to synthetic progestins, micronized progesterone tends to cause fewer mood-related side effects. Many women who experienced irritability, bloating, or depression on synthetic progestins find that switching to micronized progesterone reduces or eliminates those symptoms. The closer match to the body’s own hormone likely explains the improved tolerability for most women.

